Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Scardino
    Scardino
  5. Eastham
    Eastham
  6. Jarnagin
    Jarnagin
  7. Reuter
    Reuter
  8. D'Angelica
    D'Angelica
  9. Kingham
    Kingham
  10. Ladanyi
    Ladanyi

Groups

  1. Surgery (2069)
  2. Department of Medicine (1345)
  3. Urology (1169)
  4. Solid Tumor Oncology Division (839)
  5. Population Sciences Research Program (826)
  6. Survivorship Research (721)
  7. Epidemiology and Biostatistics (692)
  8. Sloan Kettering Institute Faculty (603)
  9. Department of Pathology and Laboratory Medicine (590)
  10. GSK Faculty (583)
Search Within
Formats
  1. Journal Article (3918)
  2. Meeting Abstract (1050)
  3. Editorial (178)
  4. Review (140)
  5. Correspondence (121)
  6. Guidelines (83)
  7. Research Letter (31)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2069)
  2. Department of Medicine (1345)
  3. Urology (1169)
  4. Solid Tumor Oncology Division (839)
  5. Population Sciences Research Program (826)
  6. Survivorship Research (721)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (229)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (163)
  6. William Jarnagin (158)

More People

Years
  1. 2025 (151)
  2. 2024 (255)
  3. 2023 (235)
  4. 2022 (263)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (768)
  2. European Urology (578)
  3. Lancet Oncology (405)
  4. Urology (391)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (276)

More Publications

Results (5556)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial
    Journal Article

    Robert, C.; Ribas, A.; Wolchok, J. D.; Hodi, F. S.; Hamid, O.; Kefford, R.; Weber, J. S.; Joshua, A. M.; Hwu, W. J.; Gangadhar, T. C.; more...
    Lancet (2014)

    Fulltext@MSK | Save
  • Second primary lung cancers: Smokers versus nonsmokers after resection of stage I lung adenocarcinoma
    Journal Article

    Ripley, R. T.; Mcmillan, R. R.; Sima, C. S.; Hasan, S. M.; Ahmad, U.; Lou, F.; Jones, D. R.; Rusch, V. W.; Rizk, N. P.; Huang, J.
    Annals of Thoracic Surgery (2014)

    Fulltext@MSK | Save
  • Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: Practice patterns at national comprehensive cancer network institutions
    Journal Article

    McCormick, B.; Ottesen, R. A.; Hughes, M. E.; Javid, S. H.; Khan, S. A.; Mortimer, J.; Niland, J. C.; Weeks, J. C.; Edge, S. B.
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure
    Journal Article

    Leung, U.; Simpson, A. L.; Araujo, R. L. C. ; Gonen, M.; McAuliffe, C.; Miga, M. I.; Parada, E. P.; Allen, P. J.; D'Angelica, M. I.; Kingham, T. P.; more...
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • Comprehensive long-term care of patients with lung cancer: Development of a novel thoracic survivorship program
    Journal Article

    Huang, J.; Logue, A. E.; Ostroff, J. S.; Park, B. J.; McCabe, M.; Jones, D. R.; Bains, M. S.; Rizk, N. P.; Kris, M. G.; Rusch, V. W.
    Annals of Thoracic Surgery (2014)

    Fulltext@MSK | Save
  • Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study
    Journal Article

    Green, D. M.; Liu, W.; Kutteh, W. H.; Ke, R. W.; Shelton, K. C.; Sklar, C. A.; Chemaitilly, W.; Pui, C. H.; Klosky, J. L.; Spunt, S. L.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): Results from the dose-finding portion of a phase 1/2 study
    Journal Article

    Gadgeel, S. M.; Gandhi, L.; Riely, G. J.; Chiappori, A. A.; West, H. L.; Azada, M. C.; Morcos, P. N.; Lee, R. M.; Garcia, L.; Yu, L.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: Results from the randomised, phase 3 AFFIRM trial
    Journal Article

    Fizazi, K.; Scher, H. I.; Miller, K.; Basch, E.; Sternberg, C. N.; Cella, D.; Forer, D.; Hirmand, M.; de Bono, J. S.
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Upper urinary tract abnormalities: A case of bilateral kidneys within a left-sided omphalocele
    Journal Article

    Derosa, R.; Musser, J. E.; Rooks, V. J.; Mcpherson, J.; McMann, L. P.
    Urology (2014)

    Fulltext@MSK | Save
  • Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
    Journal Article

    de Azambuja, E.; Holmes, A. P.; Piccart-Gebhart, M.; Holmes, E.; Di Cosimo, S.; Swaby, R. F.; Untch, M.; Jackisch, C.; Lang, I.; Smith, I.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save